TFF PharmaceuticalsTFFP
13F holders, Q4 2024 (December 31)4holders −19
0new positions
21sold out
$0.00avg. 13F price*
At the end of Q4 2024, 4 institutions reported holding TFF Pharmaceuticals Inc. (TFFP) in their 13F filings, down 19 from Q3 2024. 0 opened new positions and 21 sold out. The largest holders were SBI Securities Co., Ltd. ($196), DRW Securities, LLC ($0) and ORG Partners LLC ($0).
- Company
- TFF Pharmaceuticals Inc.
- CUSIP
- 87241J203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 21 | $1.4M |
All 13F filers, Q3 2024 → Q4 2024: 693,179 shares sold, net −693,179 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| SBI Securities Co., Ltd. | 0.00% | — | 3,010 | $196 |
| DRW Securities, LLC | 0.00% | No change | 40,000 | $0 |
| ORG Partners LLC | 0.00% | No change | 540 | $0 |
| Gen-Wealth Partners Inc | 0.00% | No change | 100 | $0 |
"% of holder's portfolio" is TFFP's weight in each manager's 13F, not the share of TFF Pharmaceuticals Inc. the manager owns.